Early-stage colorectal cancer is usually curable by surgical resection. However, approximately 30% of patients relapse, most commonly with hepatic metastasis.
Locoregional colorectal cancer recurrence after curative resection remains a clinical problem despite improvements in surgical techniques. A surgical approach is usually preferred, although controversies exist. Retrospective studies have identified risk factors that may predict successful outcomes after reoperation. In the current manuscript , the experience of our tertiary oncology center involving cases with complicated locoregional recurrences is reported. Four such patients were identified, age 55-69 years old, who were treated with an aggressive surgical intervention in the setting of multimodality treatment including postoperative chemotherapy and radiation.
Despite the presence of risk factors, such as involvement of adjacent structures, an excellent disease-free survival was achieved. We, therefore, propose that aggressive surgical approach supported by modern chemotherapy and occasionally radiotherapy for the treatment of colorectal cancer locoregional relapses should be considered in the setting of a multidisciplinary oncologic evaluation.
cancer, were identified. Four of these patients with regional relapse were identified and are presented below.
Initial selection for aggressive surgical management of locoregional relapse was based on routine computerized tomography (CT) imaging. If patients fulfilled the criteria of lack of distal metastasis, the extent of the disease was further assessed with magnetic resonance imaging (MRI) of the abdominal and retroperitoneal areas. All patients had to have undergone colonoscopy within 6 months prior to surgery; otherwise, it was performed preoperatively.
Case 1
The patient, GG, is a 55-year-old male patient who 
Case 2
The patient, OM, is a 58-year-old male patient who CEA was normal and performance status was good.
There was no evidence of distal metastasis.
After multidisciplinary consultation, he was deemed operable and underwent an extensive resection of several retroperitoneal tumors, the largest measuring 6 cm, consistent with relapse of his adenocarcinoma.
The resection was complete. The patient recovered uneventfully. His tumor was positive for K-ras mutation.
Postoperatively, he received irinotecan, leucovorin, 5-fluorouracil (FOLFIRI) with bevacizumab for six months. He remains disease-free at 40 months since his last operation.
Case 3
The patient, LS, is a 64-year-old male who underwent a resection of a supposedly T3, N0 sigmoid adenocarcinoma at another institution in August 2011.
He then came to our hospital for consideration for 
Discussion
Isolated retroperitoneal recurrence of previously resected colorectal cancer is a relatively uncommon and challenging problem, often resulting in patients' demise.
Our cases illustrate the feasibility of successful salvage resection, even of complex locoregional colon cancer recurrence, in the setting of multidisciplinary approach within an experienced tertiary center. Although not sufficiently substantiated, an aggressive approach aimed at complete resection is usually adopted.
Nevertheless, there is sparse evidence in the published medical literature regarding the merits of such an approach. In fact, a literature review published in 2011
by Ho et al [3] , involved only 110 patients.
Our small series of four patients serve to support the notion that a surgical approach is justified. Two of the four patients presented with considerable tumor bulk, one had involvement of the bladder wall and another had extension to the psoas muscle. These presentations could have possibly deterred an operation elsewhere as they are empirically considered of adverse prognosis.
Resection of the relapse seems to offer long-term benefit to patients according to published studies.
Median overall survival in the reported studies ranges between 30-40 months overall. Bowne et al. [4] , report a 66-month median survival for the R0 resection subset of 56 patients. Based on the above, it is not surprising that three out of our four patients have not relapsed.
In all of our patients, a complete R0 resection was achieved. An R0 resection seems to be the most important factor for long-term survival or cure as reported by several studies [4, 5] . In conclusion, based on our experience as well as the limited published evidence, it is reasonable to attempt surgical approach with curative intent in patients with retroperitoneal or nodal colorectal cancer recurrence.
Obviously, careful selection of suitable candidates is indicated, taking into account location of the tumor, involvement of vital structures or vessels and comorbidities. Occasionally, vascular surgery or urologic assistance may be required. It is imperative that such patients be evaluated by multidisciplinary team and referred to specialized centers staffed by experienced and skilled oncology surgeons.
